Lipids & Fatty Acids

CLA (Conjugated Linoleic Acid)

Also known as: Conjugated linoleic acid, Tonalin, CLA 80%

The beef-and-dairy fat that became a diet pill — small, real fat-loss effects with an insulin-sensitivity caveat.

By IngredientWiki Editorial Team
Fact-checked by IngredientWiki Editorial Team
Updated 2026-09-26
2 min read

In short

Conjugated linoleic acid (CLA) is a family of polyunsaturated fats found naturally in beef and dairy — and concentrated into one of the most studied weight-loss supplements of the 2000s. The pooled trial data is honest and modest: CLA produces a small but statistically significant reduction in body fat — roughly 1–2 kg over 6–12 months — without meaningful weight-loss effects on the scale. The caveat that cooled the category: the same doses can worsen insulin sensitivity and raise inflammatory markers in some studies, making the risk-benefit math uncomfortable for a supplement whose benefits are this small.

Naturally in grass-fed beef and full-fat dairy
Meta-analyses: ~1–2 kg fat reduction over 6–12 months
Little effect on body weight itself
Possible insulin-sensitivity worsening at supplement doses

What is CLA (Conjugated Linoleic Acid)?

CLA is a cautionary tale in supplement economics: a genuine bioactivity story (isomers of linoleic acid that shift fat metabolism in animals), a decade of enthusiastic human trials, and a final verdict that is real but deflating — about a kilogram or two of fat over many months, at the cost of possible metabolic side effects. The ingredient still sells on the strength of its animal data and early trials, but the mature literature describes a marginal supplement: defensible only if you accept small results, long timelines, and an honest conversation about the insulin caveat.

Where it comes from

Natural sources

Found in ruminant fats: grass-fed beef, full-fat dairy, and butter
Produced naturally in cows' stomachs by bacterial conversion of linoleic acid
The two main isomers (cis-9, trans-11 and trans-10, cis-12) have different effects

How it's made

Supplements synthesize CLA from safflower or sunflower oil; standard products are 50:50 blends of the two isomers ('Tonalin' type).

What it does in products

Benefits

Body-fat reduction

moderate evidence

Meta-analyses of randomized trials find CLA reduces fat mass by roughly 1–2 kg over 6–12 months versus placebo — real, statistically significant, and modest.

Body composition maintenance

emerging evidence

Some trials show preserved lean mass during weight-loss periods, though effects are inconsistent.

Weight loss (scale weight)

moderate evidence

Effects on actual body weight are negligible — CLA's action is on fat mass specifically, which is why the scale barely moves.

Side effects & safety

Stomach upset (uncommon)Take with meals.

Worsened insulin sensitivity (uncommon)Seen with the trans-10, cis-12 isomer at higher doses; more relevant for at-risk individuals.

Safety considerations

Avoid supplements in pregnancy — insufficient data.
None firmly established; monitor blood sugar if combining with diabetes medications.
Not for: Type 2 diabetes or metabolic syndrome (insulin-sensitivity concerns)
Not for: History of fatty liver

How it's used

In supplements

Studied dose: 3–3.4 g daily, usually in divided doses with meals, for 6–12 months. Expect slow, small fat-mass changes — CLA is a long-horizon adjunct, not a fat burner.

Regulatory status

Dietary supplement under DSHEA; GRAS-affirmed for food use. No fat-loss drug approval.
GRAS (generally recognized as safe) for food use.

The insulin caveat that cooled a category

CLA's decline from weight-loss star to niche ingredient traces to a consistent secondary finding: in overweight and insulin-resistant participants, CLA supplementation worsened insulin sensitivity and raised inflammatory markers in several trials — effects attributed to the trans-10, cis-12 isomer, which animal studies link to fatty liver. For a supplement delivering roughly a kilogram of fat loss over months, that metabolic trade-off is hard to justify, and guidelines now caution against CLA in anyone with diabetes or metabolic syndrome. The honest framing: CLA is a marginal body-composition aid best reserved for metabolically healthy people with modest goals and patience.

Frequently asked questions

Does CLA actually burn fat?

It reduces fat mass by a small, real amount — about 1–2 kg over 6–12 months in pooled trials — without meaningfully changing body weight. 'Burn' oversells it; 'nudges fat partitioning' is accurate.

What foods contain CLA?

Grass-fed beef and full-fat dairy (milk, butter, cheese) are the main sources, at far lower doses than supplements deliver. There is no evidence dietary CLA mimics supplement effects.

Who should avoid CLA?

People with diabetes, prediabetes, metabolic syndrome, or fatty liver should skip it — trials show possible insulin-sensitivity worsening. Pregnant women should also avoid it.

The bottom line

CLA is a real but marginal supplement: a kilogram or two of fat loss over many months, no scale-weight effect, and a metabolic caveat that excludes insulin-resistant users. The best use case is metabolically healthy people wanting a slow, small body-composition edge — the worst is expecting a diet pill.

References

CLA and body composition (meta-analysis). PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/?term=conjugated+linoleic+acid+body+composition+meta
CLA and insulin sensitivity — literature search. PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/?term=conjugated+linoleic+acid+insulin+sensitivity
CLA isomers and metabolism (review). PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/?term=CLA+isomers+metabolism+review
Linoleic acid compound summary. PubChem (National Library of Medicine). https://pubchem.ncbi.nlm.nih.gov/compound/5280450